Effects of insulin combined with metformin on serum cystatin C, homocysteine and maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus

Zheng,Jizeng; Xu,Juan; Zhang,Yin; Zhou,Nan

doi:10.3892/etm.2019.8224

Effects of insulin combined with metformin on serum cystatin C, homocysteine and maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus

Authors:
- Jizeng Zheng
- Juan Xu
- Yin Zhang
- Nan Zhou
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Liaocheng Third People's Hospital, Liaocheng, Shandong 252000, P.R. China, Department of Obstetrics, Tengzhou Central People's Hospital, Tengzhou, Shandong 277500, P.R. China, Department of Health Care, Jinan Central Hospital, Jinan, Shandong 250013, P.R. China
Published online on: November 20, 2019 https://doi.org/10.3892/etm.2019.8224
Pages: 467-472
Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Effects of insulin combined with metformin on serum cystatin C (Cys C), homocysteine (Hcy) and maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus (GDM) were investigated. In total, 80 cases of pregnant women diagnosed with GDM in the Department of Obstetrics and Gynecology of Liaocheng Third People's Hospital from July 2015 to July 2017 were selected and divided into a study group (42 cases) and a control group (38 cases). The study group was treated with insulin combined with metformin, and the control group was treated with insulin. Fasting blood glucose (FBG) and postprandial blood glucose after 2 h (2hPG) of the two groups were compared before and after treatment. Levels of serum Cys C, Hcy, urinary protein (UmAlb), postpartum maternal outcomes and adverse reactions during pregnancy were compared in the two groups before and after treatment. After treatment, the level of FBG and 2hPG in the control group was higher than that in the treatment group (P<0.05). After treatment, the level of serum Cys C and Hcy in both groups were lower than that before the treatment, and the level in the study group was lower than that in the control group (P<0.05). The total incidence of neonatal adverse outcomes and the number of adverse pregnancies in GDM patients in the study group were significantly lower than those in the control group (P<0.05). There were no significant differences in adverse reactions during pregnancy between the two groups (P>0.05). In conclusion, insulin combined with metformin is more effective than insulin alone in reducing serum Cys C and Hcy levels, with significant effect on the improvement of maternal and neonatal outcomes.

View Figures

View References

1	Szmuilowicz ED, Josefson JL and Metzger BE: Gestational diabetes mellitus. Endocrinol Metab Clin North Am. 48:479–493. 2019. View Article : Google Scholar : PubMed/NCBI
2	Lu X, Wu F, Jiang M, Sun X and Tian G: Curcumin ameliorates gestational diabetes in mice partly through activating AMPK. Pharm Biol. 57:250–254. 2019. View Article : Google Scholar : PubMed/NCBI
3	Ustebay S, Baykus Y, Deniz R, Ugur K, Yavuzkir S, Yardim M, Kalayci M, Çaglar M and Aydin S: Chemerin and dermcidin in human milk and their alteration in gestational diabetes. J Hum Lact. 35:550–558. 2019. View Article : Google Scholar : PubMed/NCBI
4	Budak MS, Kahramanoglu I, Vitale SG, Akgol S, Dilek ME, Kartal S, Caruso S, Kahveci B, Obut M, Bademkiran MH, et al: Maternal abdominal subcutaneous fat thickness as a simple predictor for gestational diabetes mellitus. J Perinat Med. 47:605–610. 2019. View Article : Google Scholar : PubMed/NCBI
5	Zheng H, Shen H, Oprea I, Worrall C, Stefanescu R, Girnita A and Girnita L: β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma. Proc Natl Acad Sci USA. 109:20620–20625. 2012. View Article : Google Scholar : PubMed/NCBI
6	Mitchell PL, Nachbar R, Lachance D, St-Pierre P, Trottier J, Barbier O and Marette A: Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice. Diabetes Obes Metab. 19:313–319. 2017. View Article : Google Scholar : PubMed/NCBI
7	Wan J, Hu Z, Zeng K, Yin Y, Zhao M, Chen M and Chen Q: The reduction in circulating levels of estrogen and progesterone in women with preeclampsia. Pregnancy Hypertens. 11:18–25. 2018. View Article : Google Scholar : PubMed/NCBI
8	Heerspink HJ, Andress DL, Bakris G, Brennan JJ, Correa-Rotter R, Dey J, Hou FF, Kitzman DW, Kohan D, Makino H, et al: Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Diabetes Obes Metab. 20:1369–1376. 2018. View Article : Google Scholar : PubMed/NCBI
9	Garcia-Carretero R, Vigil-Medina L, Mora-Jimenez I, Soguero-Ruiz C, Goya-Esteban R, Ramos-Lopez J and Barquero-Perez O: Cardiovascular risk assessment in prediabetic patients in a hypertensive population: The role of cystatin C. Diabetes Metab Syndr. 12:625–629. 2018. View Article : Google Scholar : PubMed/NCBI
10	Gong T, Wang J, Yang M, Shao Y, Liu J, Wu Q, Xu Q, Wang H, He X, Chen Y, et al: Serum homocysteine level and gestational diabetes mellitus: A meta-analysis. J Diabetes Investig. 7:622–628. 2016. View Article : Google Scholar : PubMed/NCBI
11	Li B, Wu J, Jiang P, Li M, Liu Q, Cao Y and Wang S: Serum fatty acid binding protein 4 is positively associated with early stroke recurrence in nondiabetic ischemic stroke. Aging (Albany NY). 11:1977–1989. 2019. View Article : Google Scholar : PubMed/NCBI
12	Maesa JM, Fernandez-Riejos P, Gonzalez-Rodriguez C and Sanchez-Margalet V: Screening for gestational diabetes mellitus by measuring glycated hemoglobin can reduce the use of the glucose challenge test. Ann Lab Med. 39:524–529. 2019. View Article : Google Scholar : PubMed/NCBI
13	Salman L, Pardo A, Krispin E, Oron G, Toledano Y and Hadar E: Perinatal outcome in gestational diabetes according to different diagnostic criteria. J Perinat Med. 47:553–557. 2019. View Article : Google Scholar : PubMed/NCBI
14	Pheiffer C, Dias S, Rheeder P and Adam S: MicroRNA profiling in HIV-infected South African women with gestational diabetes mellitus. Mol Diagn Ther. 23:499–505. 2019. View Article : Google Scholar : PubMed/NCBI
15	Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, et al HAPO Study Cooperative Research Group, : The hyperglycemia and adverse pregnancy outcome study: Associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 35:780–786. 2012. View Article : Google Scholar : PubMed/NCBI
16	Qian D, Zhang T, Zheng P, Liang Z, Wang S, Xie J, Zhao L, Zhang Y and Situ B: Comparison of oral antidiabetic drugs as add-in treatments in patients with type 2 diabetes uncontrolled on metformin: A Network Meta-Analysis. Diabetes Ther. 9:1945–1958. 2018. View Article : Google Scholar : PubMed/NCBI
17	Chaturvedi R, Desai C, Patel P, Shah A and Dikshit RK: An evaluation of the impact of antidiabetic medication on treatment satisfaction and quality of life in patients of diabetes mellitus. Perspect Clin Res. 9:15–22. 2018. View Article : Google Scholar : PubMed/NCBI
18	Li YT, Kuo TC and Wang PH: Low serum level of irisin and gestational diabetes mellitus. Taiwan J Obstet Gynecol. 58:443–444. 2019. View Article : Google Scholar : PubMed/NCBI
19	Formoso G, Ginestra F, Di Dalmazi G and Consoli A: Empagliflozin, metformin and insulin degludec, during pregnancy: A case report. Acta Diabetol. 55:759–761. 2018. View Article : Google Scholar : PubMed/NCBI
20	Chong PL, Pisharam J, Abdullah A and Chong VH: Gestational diabetes insipidus. QJM. 112:123–124. 2019. View Article : Google Scholar : PubMed/NCBI
21	Tavakoli R and Lebreton G: Biomarkers for early detection of cardiac surgery-associated acute kidney injury. J Thorac Dis. 10 (Suppl 33):S3914–S3918. 2018. View Article : Google Scholar : PubMed/NCBI
22	Ma L, Liu Q, Jiang Y, Zhao H, Zhao T, Cao Y, Li P and Niu W: Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients. J Cell Mol Med. 23:2794–2800. 2019. View Article : Google Scholar : PubMed/NCBI
23	Kawasaki M, Arata N and Ogawa Y: Obesity and abnormal glucose tolerance in the offspring of mothers with diabetes. Curr Opin Obstet Gynecol. 30:361–368. 2018. View Article : Google Scholar : PubMed/NCBI
24	Fu Z, Yang X, Shen M, Xue H, Qian G, Cao F, Guo J, Dong W and Chen Y: Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients. Clin Interv Aging. 13:1201–1209. 2018. View Article : Google Scholar : PubMed/NCBI
25	Hiersch L and Yogev Y: Impact of gestational hyperglycemia on maternal and child health. Curr Opin Clin Nutr Metab Care. 17:255–260. 2014. View Article : Google Scholar : PubMed/NCBI
26	Guillén-Sacoto MA, Barquiel B, Hillman N, Burgos MÁ and Herranz L: Gestational diabetes mellitus: Glycemic control during pregnancy and neonatal outcomes of twin and singleton pregnancies. Endocrinol Diabetes Nutr. 65:319–327. 2018. View Article : Google Scholar : PubMed/NCBI